+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North America Cardiovascular Ultrasound Market By Display, By Technology, By Type, By End Use, By Country, Growth Potential, COVID-19 Impact Analysis Report and Forecast, 2021 - 2027

  • PDF Icon

    Report

  • 95 Pages
  • August 2021
  • Region: North America
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5448363

The North America Cardiovascular Ultrasound Market is expected to witness market growth of 9.5% CAGR during the forecast period (2021-2027).

The growth of the overall market is expected to be propelled by the constant surge in the penetration of preventive medicine and surge in the occurrence of cardiovascular diseases (CVDs). Cardiovascular diseases like coronary heart disease, stroke, and heart attack are the common causes of death in the U.S. In addition, shifting lifestyle patterns have made the global population more vulnerable to CVDs. For example, as per the CDC, 28.2 million individuals were suffering from heart disease in the U.S. Ultrasound technology is utilized to check deformities in the heart’s functioning, like pumping capacity of the heart, plaque, and functioning of valves in the heart.

North America is home to some of the key market players, which is likely to further boost the growth of the regional market in the upcoming years. Factors such as the huge adoption of ultrasound modality in general diagnostics and the surge in the occurrence of lifestyle-related chronic diseases are responsible for the growth of the regional market. As per the American Heart Association, heart disease is responsible for around 14% of deaths in the United States.

Coronary Heart Disease is one of the most common causes of death in the US after Stroke, heart attack, elevated blood pressure, diseases of the arteries, and other cardiovascular diseases. Moreover, favorable initiatives to spread awareness about the diseases are estimated to boost the demand for cardiovascular devices in the region. Thus, these factors collectively will fuel the growth of the regional cardiovascular ultrasound market during the forecast years.

The US market dominated the North America B/W Display Market by Country 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $80.7 million by 2027. The Canada market is experiencing a CAGR of 7.7% during (2021 - 2027). Additionally, The Mexico market is expected to witness a CAGR of 6.7% during (2021 - 2027).

Based on Display, the market is segmented into Color Display and B/W Display. Based on Technology, the market is segmented into Doppler, 2D and 3D/4D. Based on Type, the market is segmented into Transthoracic echocardiography, Transesophageal echocardiography, Fetal echocardiography and Others. Based on End Use, the market is segmented into Hospital, Diagnostic centers, Ambulatory care centers and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.



The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Koninklijke Philips N.V., Siemens AG (Siemens Healthineers), Samsung Electronics Co., Ltd. (Samsung Group) (Samsung Medison Co., Ltd.), Mindray Medical International Limited, Chison Medical Technologies Co., Ltd., FUJIFILM Sonosite, Inc. (Fujifilm Holdings Corporation), Canon, Inc. (Canon Medical Systems Corporation) and Esaote SpA.



Scope of the Study

Market Segments Covered in the Report:


By Display

  • Color Display and
  • B/W Display

By Technology

  • Doppler
  • 2D and
  • 3D/4D

By Type

  • Transthoracic echocardiography
  • Transesophageal echocardiography
  • Fetal echocardiography and
  • Others

By End Use

  • Hospital
  • Diagnostic centers
  • Ambulatory care centers and
  • Others

By Country

  • US
  • Canada
  • Mexico
  • Rest of North America

Key Market Players

List of Companies Profiled in the Report:


  • General Electric (GE) Co. (GE Healthcare)
  • Koninklijke Philips N.V.
  • Siemens AG (Siemens Healthineers)
  • Samsung Electronics Co., Ltd. (Samsung Group) (Samsung Medison Co., Ltd.)
  • Mindray Medical International Limited
  • Chison Medical Technologies Co., Ltd.
  • FUJIFILM Sonosite, Inc. (Fujifilm Holdings Corporation)
  • Canon, Inc. (Canon Medical Systems Corporation)
  • Esaote SpA

Unique Offerings from the Publisher

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Cardiovascular Ultrasound Market, by Display
1.4.2 North America Cardiovascular Ultrasound Market, by Technology
1.4.3 North America Cardiovascular Ultrasound Market, by Type
1.4.4 North America Cardiovascular Ultrasound Market, by End Use
1.4.5 North America Cardiovascular Ultrasound Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 COVID-19 Impact
2.1.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansions
3.2.5 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions : 2018, Aug - 2021, May) Leading Players
Chapter 4. North America Cardiovascular Ultrasound Market by Display
4.1 North America Color Display Market by Country
4.2 North America B/W Display Market by Country
Chapter 5. North America Cardiovascular Ultrasound Market by Technology
5.1 North America Doppler Market by Country
5.2 North America 2D Market by Country
5.3 North America 3D/4D Market by Country
Chapter 6. North America Cardiovascular Ultrasound Market by Type
6.1 North America Transthoracic echocardiography Market by Country
6.2 North America Transesophageal echocardiography Market by Country
6.3 North America Fetal echocardiography Market by Country
6.4 North America Other Type Market by Country
Chapter 7. North America Cardiovascular Ultrasound Market by End Use
7.1 North America Hospital Market by Country
7.2 North America Diagnostic centers Market by Country
7.3 North America Ambulatory care centers Market by Country
7.4 North America Others Market by Country
Chapter 8. North America Cardiovascular Ultrasound Market by Country
8.1 US Cardiovascular Ultrasound Market
8.1.1 US Cardiovascular Ultrasound Market by Display
8.1.2 US Cardiovascular Ultrasound Market by Technology
8.1.3 US Cardiovascular Ultrasound Market by Type
8.1.4 US Cardiovascular Ultrasound Market by End Use
8.2 Canada Cardiovascular Ultrasound Market
8.2.1 Canada Cardiovascular Ultrasound Market by Display
8.2.2 Canada Cardiovascular Ultrasound Market by Technology
8.2.3 Canada Cardiovascular Ultrasound Market by Type
8.2.4 Canada Cardiovascular Ultrasound Market by End Use
8.3 Mexico Cardiovascular Ultrasound Market
8.3.1 Mexico Cardiovascular Ultrasound Market by Display
8.3.2 Mexico Cardiovascular Ultrasound Market by Technology
8.3.3 Mexico Cardiovascular Ultrasound Market by Type
8.3.4 Mexico Cardiovascular Ultrasound Market by End Use
8.4 Rest of North America Cardiovascular Ultrasound Market
8.4.1 Rest of North America Cardiovascular Ultrasound Market by Display
8.4.2 Rest of North America Cardiovascular Ultrasound Market by Technology
8.4.3 Rest of North America Cardiovascular Ultrasound Market by Type
8.4.4 Rest of North America Cardiovascular Ultrasound Market by End Use
Chapter 9. Company Profiles
9.1 General Electric (GE) Co. (GE Healthcare)
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Product Launches and Product Expansions:
9.1.5.3 Approval and Trials
9.2.5 Recent strategies and developments:
9.2.5.2 Product Launches and Product Expansions
9.2.5.3 Geographical Expansion
9.2.5.4 Approvals and Trials
9.3 Siemens AG (Siemens Healthineers)
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent Strategies and Development:
9.3.5.1 Product Launches and Product Expansions
9.3.5.2 Approval and Trials
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.5 Mindray Medical International Limited
9.5.1 Company Overview
9.6 Chison Medical Technologies Co., Ltd.
9.6.1 Company Overview
9.7 FUJIFILM Sonosite, Inc. (Fujifilm Holdings Corporation)
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 Recent strategies and developments:
9.7.5.1 Partnerships, Collaborations and Agreements:
9.7.5.2 Product Launches and Product Expansions:
9.7.5.3 Acquisition and Mergers:
9.8.1 Company Overview
9.8.1 Financial Analysis
9.8.2 Segmental and Regional Analysis
9.8.3 Research & Development Expenses
9.9.2 Recent strategies and developments:
9.9.2.1 Partnerships, Collaborations, and Agreements:
9.9.2.2 Product Launches and Product Expansions:

Companies Mentioned

  • General Electric (GE) Co. (GE Healthcare)
  • Koninklijke Philips N.V.
  • Siemens AG (Siemens Healthineers)
  • Samsung Electronics Co., Ltd. (Samsung Group) (Samsung Medison Co., Ltd.)
  • Mindray Medical International Limited
  • Chison Medical Technologies Co., Ltd.
  • FUJIFILM Sonosite, Inc. (Fujifilm Holdings Corporation)
  • Canon, Inc. (Canon Medical Systems Corporation)
  • Esaote SpA

Methodology

Loading
LOADING...